top of page
Recent Posts
See AllTORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research a
Using the platform powered by advanced AI algorithms, Rakovina can quickly analyze billions of molecular structures ..
The Company expects to submit the Type C meeting request by next week.
© 2023 Frontier Merchant Capital Group. All Rights Reserved.
bottom of page